Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Multiple Myeloma

FDA Grants Orphan Drug Designation to BCMA-targeting Specific T Cell Activating Recombinant Protein (HPN217) for Patients with Multiple Myeloma

The U.S. Food and Drug Administration decided to open the Orphan Drug Designation (ODD) to an investigational drug for the […]

FDA Grants Orphan Drug Designation to BCMA-targeting Specific T Cell Activating Recombinant Protein (HPN217) for Patients with Multiple Myeloma
1 month ago
Share

The MMRF CureCloud Multiple Myeloma Research Initiative: Precision Medicine Around the Corner?

The CureCloud study, sponsored by the Multiple Myeloma Research Foundation, seeks to 1) bring the latest cutting-edge discoveries in multiple […]

The MMRF CureCloud Multiple Myeloma Research Initiative Precision Medicine Around the Corner
7 months ago
Share

State of the Science for Multiple Myeloma: Change in the Right Direction

In a workshop held by the FDA in partnership with the American Association for Cancer Research (AACR) on February 13, […]

State of the Science for Multiple Myeloma Change in the Right Direction
1 year ago
Share

Huntsman Cancer Institute Researchers Pursue Powerful CAR T Therapy for Multiple Myeloma

Researchers at the Huntsman Cancer Institute (HCI) at the University of Utah (U of U) report on a novel way […]

Huntsman Cancer Institute Researchers Pursue Powerful CAR T Therapy for Multiple Myeloma
1 year ago
Share

Clinical Investigators Focusing on benefits of Reolysin, Kyprolis Combination in Multiple Myeloma

Oncolytics Biotech’s virus-based anti-cancer therapy Reolysin (pelareorep) has the attention of top researchers from Winship Cancer Center and City of Hope […]

Clinical Investigators Focusing on benefits of Reolysin, Kyprolis Combination in Multiple Myeloma
1 year ago
Share

I-Mab Biopharma Reports it Doses First Mainland Chinese Multiple Myeloma Patient in Pivotal Phase II Trial

I-Mab Biopharma dosed its first patient in mainland China as part of its ongoing pivotal Phase II trial evaluating an experimental […]

I-Mab Biopharma Reports it Doses First Mainland Chinse Multiple Myeloma Patient in Pivotal Phase II Trial
1 year ago
Share

MMRF Showcases CoMMpass StudySM at Upcoming American Society of Hematology Annual Meeting

The Multiple Myeloma Research Foundation (MMRF) announced that 34 abstracts will be presented at the 61st American Society of Hematology Annual […]

MMRF Showcases CoMMpass StudySM at Upcoming American Society of Hematology Annual Meeting
1 year ago
Share

Cancer Treatment Centers of America Investigators Dose First Patient in Experimental Immuno-Oncology Clinical Trial

Cancer Treatment Centers of America® (CTCA) clinical investigators based in Phoenix have dosed the first patient in the first-in-human study […]

Cancer Treatment Centers of America Investigators Dose First Patient in Experimental Immuno-Oncology Clinical Trial
1 year ago
Share

ASH Research Collaborative Data Hub Receives Shared Industry Datasets from Novartis & Amgen

The ASH Research Collaborative (ASH RC) has collaborated with two industry leaders, Novartis and Amgen, to include de-identified patient data […]

ASH Research Collaborative Data Hub Receives Shared Industry Datasets from Novartis & Amgen
1 year ago
Share

Fred Hutchinson CAR-T Cell Therapy Shows Results for Patient in Phase I Clinical Trial

Fred Hutchinson Cancer Research Center is an amazing place. At the forefront of combating cancer, recently they recently served as […]

Fred Hutchinson CAR-T Cell Therapy Shows Results for Patient in Phase I Clinical Trial
1 year ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.